Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Ultra Bloomberg Natural Gas ETF (BOIL) vs Cronos Group Inc (CRON) Price & Performance

ProShares Ultra Bloomberg Natural Gas ETFTrade
Cronos Group IncTrade

Price performance (Past 24H)

Key statistics

ProShares Ultra Bloomberg Natural Gas ETF vs Cronos Group Inc — how do they compare? ProShares Ultra Bloomberg Natural Gas ETF trades at $20.8, while Cronos Group Inc trades at $3.08 (market cap $1.11B). The key difference: Cronos Group Inc is trading nearer its 52-week high, ProShares Ultra Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.

BOILCRON
Sector
Leveraged / InverseHealth
52-Week High
$87.24$3.27
52-Week Low
$18.74$2.30
Market Cap
$1.11B
Enterprise Value
$310.67M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares Ultra Bloomberg Natural Gas ETF

BOIL trades at $19.12, up 2.03% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The stock faces resistance near $20 and support at $18. Recent news highlights natural gas market volatility and company-specific updates, including an investor webcast and annual meeting results. Financial ratios are unavailable, limiting fundamental assessment.

The outlook remains cautious due to bearish technicals and reliance on natural gas price swings. Risks include energy market fluctuations and competitive pressures. Analyst sentiment is mixed, with some viewing BOIL as a tactical tool amid volatility, but the lack of fundamental data warrants careful evaluation for long-term investment.

Cronos Group Inc

CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.

Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ProShares Ultra Bloomberg Natural Gas ETF

BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.

Read more on BOIL

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON